1. A long-term open-label safety study of galcanezumab in Japanese patients with migraine. Issue 6 (3rd June 2021) Authors: Hirata, Koichi; Takeshima, Takao; Sakai, Fumihiko; Tatsuoka, Yoshihisa; Suzuki, Norihiro; Igarashi, Hisaka; Nakamura, Tomomi; Ozeki, Akichika; Yamazaki, Hiroyoshi; Skljarevski, Vladimir Journal: Expert opinion on drug safety Issue: Volume 20:Issue 6(2021) Page Start: 721 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effect of Galcanezumab Following Treatment Cessation in Patients With Migraine: Results From 2 Randomized Phase 3 Trials. Issue 6 (3rd April 2019) Authors: Stauffer, Virginia L.; Wang, Shufang; Voulgaropoulos, Menelaos; Skljarevski, Vladimir; Kovacik, Amy; Aurora, Sheena K. Journal: Headache Issue: Volume 59:Issue 6(2019) Page Start: 834 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy and Safety of Duloxetine in Patients with Chronic Low Back Pain Who Used versus Did Not Use Concomitant Nonsteroidal Anti-Inflammatory Drugs or Acetaminophen: A Post Hoc Pooled Analysis of 2 Randomized, Placebo-Controlled Trials. (18th March 2012) Authors: Skljarevski, Vladimir; Liu, Peng; Zhang, Shuyu; Ahl, Jonna; Martinez, James M. Other Names: Ortiz Mario I. Academic Editor. Journal: Pain research and treatment Issue: Volume 2012(2012) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy and safety of galcanezumab for prevention of migraine headache in Japanese patients with episodic migraine: A phase 2 randomized controlled clinical trial. (2nd July 2020) Authors: Sakai, Fumihiko; Ozeki, Akichika; Skljarevski, Vladimir Journal: Cephalalgia reports Issue: Volume 3(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial. (July 2018) Authors: Skljarevski, Vladimir; Matharu, Manjit; Millen, Brian A; Ossipov, Michael H; Kim, Byung-Kun; Yang, Jyun Yan Journal: Cephalalgia Issue: Volume 38:Number 8(2018) Page Start: 1442 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Efficacy of Galcanezumab for Migraine Prevention in Patients With a Medical History of Anxiety and/or Depression: A Post Hoc Analysis of the Phase 3, Randomized, Double‐Blind, Placebo‐Controlled REGAIN, and Pooled EVOLVE‐1 and EVOLVE‐2 Studies. Issue 10 (16th October 2020) Authors: Smitherman, Todd A.; Tietjen, Gretchen E.; Schuh, Kory; Skljarevski, Vladimir; Lipsius, Sarah; D'Souza, Deborah N.; Pearlman, Eric M. Journal: Headache Issue: Volume 60:Issue 10(2020) Page Start: 2202 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Evaluation of the CGRP Neutralizing Antibody LY2951742 for the Treatment of Migraine and Osteoarthritis Pain. (October 2017) Authors: Johnson, Kirk; Skljarevski, Vladimir; Zhang, Qi; Ferguson, Margaret; Oakes, Tina; Martinez, James; Monteith, David; Jin, Yan; Smith, Claire; Chambers, Mark; Siegel, Miles; Benschop, Robert; Schacht, Aaron Journal: Neuropeptides Issue: Volume 65(2017) Page Start: 134 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Measures of Functioning in Patients With Episodic Migraine: Findings From a Double‐Blind, Randomized, Placebo‐Controlled Phase 2b Trial With Galcanezumab. Issue 8 (14th August 2018) Authors: Ayer, David W.; Skljarevski, Vladimir; Ford, Janet H.; Nyhuis, Allen W.; Lipton, Richard B.; Aurora, Sheena K. Journal: Headache Issue: Volume 58:Issue 8(2018) Page Start: 1225 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Monoclonal antibodies for chronic pain: A practical review of mechanisms and clinical applications. Issue 1 (November 2017) Authors: Yeh, Ju-Fen; Akinci, Aysen; Al Shaker, Mohammed; Chang, Ming Hong; Danilov, Andrei; Guillen, Rocio; Johnson, Kirk W; Kim, Yong-Chul; El-Shafei, Ahmed A; Skljarevski, Vladimir; Dueñas, Héctor J; Tassanawipas, Warat Journal: Molecular pain Issue: Volume 13:Issue 1(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Onset of efficacy and duration of response of galcanezumab for the prevention of episodic migraine: a post-hoc analysis. Issue 8 (19th April 2019) Authors: Goadsby, Peter J; Dodick, David W; Martinez, James M; Ferguson, Margaret B; Oakes, Tina M; Zhang, Qi; Skljarevski, Vladimir; Aurora, Sheena K Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 90:Issue 8(2019) Page Start: 939 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗